As they discussed the decision this week, top health officials warned the White House about uncertainty over how vaccines might respond to a homegrown virus variant in India.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register. By continuing to use this site, you are consenting to our use of cookies.